As for the immune microenvironment of glioma, samples with higher risk demonstrated higher percentages of resting CD4+ memory T cells, M1, M2 macrophages, and activated dendritic cells in both cohorts (Figures 7E,F and Supplementary Table 4). The gene discussed is CD4; the disease is glioma.